Clinical TrialsSearch results
Number of results: 228
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in rectal cancer surgery
- Patients undergoing elective rectal cancer surgery
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2008-01-25
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in total gastrectomy for gastric cancer.
- Gastric cancer patients undergoing elective total gastrectomy
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2008-03-03
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Randomized pilot study comparing safety of irinotecan+S-1(IRIS)+bevacizumab and mFOLFIRI+bevacizumab for metastatic colorectal cancer (T-CORE0702)
- 1st line or 2nd line therapy for unresectable colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2007-07-22
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- The changes of QOL in patients with Alzherimer's disease through medical treatment: an observational study
- Alzheimer's disease
- Non Profit Organization Institute of Community Medicine and Welfare for Central Nervous System
- 2008-07-19